Cargando…
Diffuse hemispheric glioma, H3 G34-mutant: Genomic landscape of a new tumor entity and prospects for targeted therapy
Autores principales: | Lucas, Calixto-Hope G, Mueller, Sabine, Reddy, Alyssa, Taylor, Jennie W, Oberheim Bush, Nancy Ann, Clarke, Jennifer L, Chang, Susan M, Gupta, Nalin, Berger, Mitchel S, Perry, Arie, Phillips, Joanna J, Solomon, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628364/ https://www.ncbi.nlm.nih.gov/pubmed/34519829 http://dx.doi.org/10.1093/neuonc/noab184 |
Ejemplares similares
-
Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma
por: López, Giselle, et al.
Publicado: (2017) -
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults
por: Schulte, Jessica D, et al.
Publicado: (2020) -
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
por: Picart, Thiébaud, et al.
Publicado: (2021) -
Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect
por: Gibson, David, et al.
Publicado: (2023) -
Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma
por: Lucas, Calixto-Hope G., et al.
Publicado: (2021)